Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study

Larochelle, Marc R., Bernson, Dana, Land, Thomas, Stopka, Thomas J., Wang, Na, Xuan, Ziming, Bagley, Sarah M., Liebschutz, Jane M., Walley, Alexander Y.·2018·Annals of Internal Medicine

DOI 10.7326/m17-3107

Cited by (1,000)

Items 401–500 of 1,000

“You might be nice, but where you take me, they're not gonna be”: Preferences for field‐based post‐overdose interventions
Jenna van Draanen, Addy Adwell, Courteney Wettemann, Callan Elswick Fockele, Brenda Y. Goh, David L. Perlmutter, Grover “Will” Williams, Nathan Holland, Tessa M. Frohe · 2024 · Drug and Alcohol Review
Emergency Department Evaluation of the Adult Psychiatric Patient
Lauren M. Nentwich, Curtis W. Wittmann · 2020 · Emergency Medicine Clinics of North America
Randomized trial of methadone treatment of arrestees: 24-month post-release outcomes
Robert P. Schwartz, Sharon M. Kelly, Shannon Gwin Mitchell, Kevin E. O’Grady, Tiffany Duren, Anjalee Sharma, Jan Gryczynski, Jerome H. Jaffe · 2020 · Drug and Alcohol Dependence
Engagement in drug treatment following nonfatal overdose among people who inject drugs in Appalachia
Sean T. Allen, Patrick T. Wedlock, Rebecca Hamilton White, Kristin E. Schneider, Allison O’Rourke, Neha Jia Ahmad, Brian W. Weir, Michael E. Kilkenny, Susan G. Sherman · 2021 · International Journal of Drug Policy
Implementation of office-based buprenorphine treatment for opioid use disorder
Emily Jean Carroll · 2021 · Journal of the American Association of Nurse Practitioners
Changing Nurse Practitioner Students' Attitudes and Beliefs About Caring for Those With Opioid Use Disorders
Kathleen M. Elliott, Elizabeth Danells Chin, Kathryn Louise Gramling, Kristen A. Sethares · 2021 · Journal of Addictions Nursing
Criminal Problem-Solving and Civil Dependency Court Policies regarding Medications for Opioid use Disorder
Barbara Andraka‐Christou, MH Clark, Danielle N. Atkins, Brandon del Pozo · 2021 · Substance Abuse
Characterizing opioid-involved overdose risk in local communities: An opioid overdose vulnerability assessment across Indiana, 2017
Jared L. Sawyer, Shikhar Shrestha, Jennifer C. Pustz, Robert Gottlieb, Deborah Nichols, Michelle M. Van Handel, Cailyn Lingwall, Thomas J. Stopka · 2021 · Preventive Medicine Reports
Treating Opioid Use Disorder in General Medical Settings
2021 · Springer eBooks
Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study
Jessica Heil, Valerie S. Ganetsky, Matthew Salzman, Krystal M Hunter, Kaitlan Baston, Gerard G. Carroll, Eric M. Ketcham, Rachel Haroz · 2022 · Western Journal of Emergency Medicine
Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative
Ashley O. Radmall, Spencer G. Calder, Nodira K. Codell, Alan Taylor Kelley, Eric J. Hawkins, Audrey L. Jones, Hildi Hagedorn, Mary Anne Reynolds, Adam J. Gordon · 2022 · Journal of Addictions Nursing
Medicaid Managed Care: Access To Primary Care Providers Who Prescribe Buprenorphine
Mark Katz Meiselbach, Coleman Drake, Brendan K. Saloner, Jane M. Zhu, Bradley D. Stein, Daniel E. Polsky · 2022 · Health Affairs
Long-term patient outcomes following buprenorphine/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population
Md Mahmudul Hasan, Md. Noor‐E‐Alam, Jiesheng Shi, Leonard D. Young, Gary J. Young · 2022 · The American Journal of Drug and Alcohol Abuse
Improved Emergency Medicine Physician Attitudes Towards Individuals with Opioid Use Disorder Following Naloxone Kit Training
Giselle Appel, Joseph J. Avery, Kaylee Ho, Zhanna Livshits, Rama B. Rao, Jonathan Avery · 2019 · The American Journal of Emergency Medicine
Buprenorphine Treatment Intake and Critical Encounters following a Nonfatal Opioid Overdose
Grant A. Victor, Katie Bailey, Bradley R. Ray · 2021 · Substance Use & Misuse
Analysis of genetic and clinical factors associated with buprenorphine response
Richard C. Crist, Rachel Vickers‐Smith, Rachel L. Kember, Christopher T. Rentsch, Heng Xu, Eva Jennifer Edelman, Emily E. Hartwell, Kyle Matthew Kampman, Henry R. Kranzler · 2021 · Drug and Alcohol Dependence
Pharmacists' role in buprenorphine management for opioid use disorder: A narrative review
Jacqueline Cleary, Amanda L. Engle, Amanda R. McFee Winans · 2021 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
A Novel Inpatient Buprenorphine Induction Program for Adolescents With Opioid Use Disorder
Lee A. Trope, Monica Stemmle, Annie Chang, Nasrin Bashiri, Alexander R. Bazazi, Marguerita A. Lightfoot, Jayme L. Congdon · 2023 · Hospital Pediatrics
Daily opioid and stimulant co-use and nonfatal overdoses in the context of social disadvantage: Findings on marginalized populations
Abenaa Acheampong Jones, Kristin E. Schneider, Karin Elizabeth Tobin, Deirdre O’Sullivan, Carl Asher Latkin · 2023 · Journal of Substance Use and Addiction Treatment
Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder
Carla Costa Garcia, Mark Bounthavong, Adam J. Gordon, Allison M. Gustavson, Marie E. Kenny, W Miller, Aryan Esmaeili, Princess E. Ackland, Barbara Ann Clothier, Ann Kay Bangerter et al. · 2023 · Implementation Science Communications
Expanding access to medication treatment for opioid use disorders: Findings from the Washington State hub and spoke effort
Maureen T. Stewart, Shay M. Daily, Cindy Lou Parks, Lee Panas, Grant A. Ritter, Sharon Reif · 2024 · Drug and Alcohol Dependence
Overview of best practices for buprenorphine initiation in the emergency department
Terence M. Hughes, Nicholas Nasser, Avir Mitra · 2024 · International Journal of Emergency Medicine
Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder
Jessica J. B. Wyse, Alison C. Eckhardt, Dylan E. Waller, Adam J. Gordon, Sarah Shull, Travis I. Lovejoy, Katherine Mackey, Benjamin J. Morasco · 2024 · Journal of Addiction Medicine
Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review
Simeon D. Kimmel, Paxton Bach, Alexander Yale Walley · 2020 · Journal of General Internal Medicine
Merging statewide data in a public/university collaboration to address opioid use disorder and overdose
William C. Becker, Robert Heimer, Catherine M. Dormitzer, Molly Doernberg, Gail D’Onofrio, Lauretta E. Grau, Kathryn F. Hawk, Hsiu‐Ju Lin, Alex M. Secora, David A. Fiellin · 2021 · Addiction Science & Clinical Practice
Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18
Bradley D. Stein, Christopher McCall Jones, Rosanna Smart, Flora Sheng, Mark Sorbero · 2021 · Drug and Alcohol Dependence
A State Financial Incentive Policy to Improve Emergency Department Treatment for Opioid Use Disorder: A Qualitative Study
Austin S. Kilaru, Su Fen Lubitz, Jessica Davis, Whitney Eriksen, Sari Siegel, David Kelley, Jeanmarie Perrone, Zachary F. Meisel · 2021 · Psychiatric Services
How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value
Nick J Bansback, Carolina Barbosa, Joshua A. Barocas, Ahmed M. Bayoumi, Czarina Navos Behrends, Jag Chhatwal, Lauren E. Cipriano, Phillip Oliver Coffin, Jeremy D. Goldhaber‐Fiebert, Jeffrey S. Hoch et al. · 2020 · International Journal of Drug Policy
“Nobody Knows How You’re Supposed to Interpret it:” End-user Perspectives on Prescription Drug Monitoring Program in Massachusetts
Mina Hong, Sarah Seymour, Thomas J. Stopka, Lane Bandanza, Erin Crocker, Allison Morgan, Leo A. Beletsky · 2021 · Journal of Addiction Medicine
The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island
Laura C. Chambers, Benjamin D. Hallowell, Xiao Zang, David M. Rind, Gregory F. Guzauskas, Ryan N. Hansen, Nathaniel Fuchs, Rachel P. Scagos, Brandon D. L. Marshall · 2022 · International Journal of Drug Policy
Binge Eating, Purging, and Restriction Symptoms: Increasing Accuracy of Prediction Using Machine Learning
Cheri A. Levinson, Christopher M. Trombley, Leigh C. Brosof, Brenna M. Williams, Rowan A. Hunt · 2022 · Behavior Therapy
A population-based study on the risk of prescription opioid abuse in patients with chronic opioid use and cost-effectiveness of prescription drug monitoring program using a patient simulation model in South Korea
Siin Kim, Hae Sun Suh · 2023 · International Journal of Drug Policy
Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
Payel Jhoom Roy, Katherine Callaway Kim, Katie J. Suda, Jing Luo, Xiaoming Wang, Donna M. Olejniczak, Jane M. Liebschutz · 2023 · Drug and Alcohol Dependence Reports
Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial
Ryan P. McCormack, John Rotrosen, Phoebe R Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch, Patricia Novo, David Liu, Eva Jennifer Edelman, Sarah Farkas et al. · 2023 · Annals of Emergency Medicine
National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder
Ethan A. Cowan, Jeanmarie Perrone, Steven L. Bernstein, Edouard Coupet, David A. Fiellin, Kathryn F. Hawk, Andrew A. Herring, Kristen Huntley, Ryan P. McCormack, Arjun K. Venkatesh et al. · 2023 · Annals of Emergency Medicine
Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky
Shikhar Shrestha, Megan Lindstrom, Daniel R. Harris, Peter J. Rock, Sumeeta Srinivasan, Jennifer C. Pustz, Ric Bayly, Thomas J. Stopka · 2023 · Journal of Substance Use and Addiction Treatment
Creation of a data commons for substance misuse related health research through privacy-preserving patient record linkage between hospitals and state agencies
Majid Afshar, Madeline K. Oguss, Thomas Callaci, Tim Gruenloh, Preeti Gupta, Claire Xin Sun, Askar Safipour Afshar, Joseph Cavanaugh, Matthew M. Churpek, Edwin E Nyakoe-Nyasani et al. · 2023 · JAMIA Open
Harm Reduction Approaches for Opioid Use Disorder
Sarah E. Wakeman · 2019 · Current clinical psychiatry
Help Is on the Way: Medicare Coverage of Opioid Treatment Programs
Cynthia Felix, Joshua M. Sharfstein, Yngvild K. Olsen · 2019 · Journal of the American Geriatrics Society
Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder
Corey S. Davis, Derek H. Carr, Melody J. Glenn, Elizabeth A. Samuels · 2021 · Annals of Emergency Medicine
Methadone Destabilizes Cardiac Repolarization During Sleep
Soroosh Solhjoo, Naresh M. Punjabi, Andrada E. Ivanescu, Ciprian M. Crainiceanu, Irina Gaynanova, Cassie Wicken, Chester C. Buckenmaier, Mark C. Haigney · 2021 · Clinical Pharmacology & Therapeutics
Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost‐effectiveness analysis
Alexandra A. Savinkina, Rajapaksha W. M. A. Madushani, Golnaz Eftekhari Yazdi, Jianing Wang, Joshua A. Barocas, Jake R. Morgan, Sabrina A. Assoumou, Alexander Yale Walley, Benjamin Paul Linas, Sean M. Murphy · 2022 · Addiction
Buprenorphine Treatment Duration and Adherence Among Youth and Subsequent Health Outcomes
Scott Evan Hadland, Simeon D. Kimmel, Shapei Yan, Amy L. Bettano, Wei‐Hsuan Lo‐Ciganic, Sarah Mary Bagley, Jessica B. Calihan, Heather Hsu, Marc R. Larochelle · 2025 · PEDIATRICS
Primary care management of Long-Term opioid therapy
P. Coffin, Rebecca S. Martinez, B. Wylie, Bunny Ryder · 2022 · Annals medicus
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
Feitong Lei, Michelle R. Lofwall, Jana McAninch, Reuben Adatorwovor, Emily Slade, Patricia Rippetoe Freeman, Daniela C. Moga, Nabarun Dasgupta, SHARON L. WALSH, Rachel Vickers‐Smith et al. · 2024 · Journal of Addiction Medicine
Mobile clinics for opioid use disorders: What they do and how they do it. A qualitative analysis
Margot Trotter Davis, Cynthia A. Tschampl, Dominic Hodgkin, Craig Regis, Elsie M. Taveras, Ben Plant, Brittni Reilly, Constance M. Horgan · 2024 · Journal of Substance Use and Addiction Treatment
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Thomas J. Stopka, Rebecca E. Rottapel, Peter D. Friedmann, Ekaterina Pivovarova, Elizabeth Evans · 2024 · Addiction Science & Clinical Practice
“Tethered to this ball and chain”: Women's perspectives on bodily agency within opioid treatment programs
Aden McCracken, Kristina Brant, Carl Asher Latkin, Abenaa Acheampong Jones · 2024 · International Journal of Drug Policy
Abuses of FDA Regulatory Procedures — The Case of Suboxone
Rebecca L. Haffajee, Richard G. Frank · 2020 · New England Journal of Medicine
The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
Colleen Jordan, Amy L. Kennalley, Tenzing Dolma, Kaitlyn M. Nemes, Alivia Roberts, Brian J. Piper · 2022 · Pharmacy
Care Management of Comorbid Medical and Psychiatric Illness: A Conceptual Framework for Improving Equity of Care
Lisa C Rosenfeld, Philip Wang, Jackie Holland, Matthew W. Ruble, Taft Parsons, Hsiang Yu Huang · 2022 · Population Health Management
The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations
Lisa A. Marsch, Ching-Hua Chen, Sara R. Adams, Asma H. Asyyed, Monique B. Does, Saeed Hassanpour, Emily G. Hichborn, Melanie Jackson-Morris, Nicholas C. Jacobson, Heather K. Jones et al. · 2022 · Frontiers in Psychiatry
The Massachusetts public health data warehouse and the opioid epidemic: A qualitative study of perceived strengths and limitations for advancing research
Elizabeth Evans, Elizabeth Delorme, Karl D. Cyr, Kimberley H. Geissler · 2022 · Preventive Medicine Reports
Resident attitudes, experiences, and preferences on initiating buprenorphine in the emergency department: A national survey
Megan Yu, Kathryn F. Hawk · 2022 · AEM Education and Training
Opioid Agents and Cardiac Arrhythmia: A Literature Review
Azamatov Golibkhon, Akbar Bazarbaev, Muzaffar Makhamadjonov Farkhod Ugli · 2023 · Cureus
A qualitative exploration of barriers and facilitators to drug treatment services among people who inject drugs in West Virginia
Abigail K. Winiker, Kristin E. Schneider, Rebecca Hamilton White, Allison O’Rourke, Suzanne M. Dolwick Grieb, Sean T. Allen · 2023 · Harm Reduction Journal
Linkage of public health and all payer claims data for population‐level opioid research
Sara E. Hallvik, Nazanin Dameshghi, Sanae El Ibrahimi, Michelle A. Hendricks, Christi Hildebran, Carissa J. Bishop, Scott G. Weiner · 2021 · Pharmacoepidemiology and Drug Safety
Assessing the impact of the Good Samaritan Law in the state of Connecticut: a system dynamics approach
Nasim S. Sabounchi, Rebekah Heckmann, Gail D’Onofrio, Jennifer Walker, Robert Heimer · 2022 · Health Research Policy and Systems
“ One Size does not Fit All ” and other Lessons Learned from Grants for Implementation of the Ahrq Medication Assisted Treatment for Opioid use Disorder in Rural Primary Care
Parivash A. Nourjah, Elizabeth Kato · 2021 · Substance Abuse
An Urgent Need to Focus on Youth With Opioid Use Disorder
Jacqueline Deanna Wilson, Sarah Mary Bagley · 2022 · Journal of Adolescent Health
Reachable Moment: Hospital-Based Interventions
Zoe Weinstein, Honora L. Englander · 2021 · Springer eBooks
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018
Kevin Paul Conway, Dalia Y. Khoury, Rainer Hilscher, Arnie Aldridge, Stephanie J. Parker, Gary A. Zarkin · 2022 · Addiction Science & Clinical Practice
A pilot study investigating cognitive impairment associated with opioid overdose
James Joseph Mahoney, Erin L. Winstanley, Felipe Castillo, Rachel R. Luba, Jennifer L. Marton, Daniel M. Alschuler, Ying Liu, Sandra D. Comer · 2023 · Drug and Alcohol Dependence
Substance Use Disorders in Adolescents and Young Adults: History and Perioperative Considerations From the Society for Pediatric Pain Medicine
Jamie Kitzman, Veronika V. Mesheriakova, Amber N. Borucki, Rita Agarwal · 2023 · Anesthesia & Analgesia
Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings
Lindsay A. Bowman, Olivia Berger, Suzanne Amato Nesbit, Kenneth B. Stoller, Megan E. Buresh, Rosalyn Walker Stewart · 2023 · American Journal of Health-System Pharmacy
Reducing overdose deaths among persons with opioid use disorder in connecticut
Joy D. Scheidell, Tarlise Townsend, Qinlian Zhou, Prima Manandhar-Sasaki, Ramon Rodriguez-Santana, Mark G. Jenkins, Marianne Buchelli, Dyanna L. Charles, Jillian M. Frechette, Jasmine I.-Shin Su et al. · 2024 · Harm Reduction Journal
Effect of a peer‐led emergency department behavioral intervention on non‐fatal opioid overdose: 18‐month outcome in the Navigator randomized controlled trial
Laura C. Chambers, Yu Li, Benjamin D. Hallowell, Kirsten J. Langdon, Elizabeth A. Samuels, Linda Mahoney, Francesca L. Beaudoin, Brandon D. L. Marshall · 2024 · Addiction
Harm Reduction in the Field: First Responders’ Perceptions of Opioid Overdose Interventions
Callan Elswick Fockele, Tessa M. Frohe, Owen McBride, David L. Perlmutter, Brenda Y. Goh, Grover Williams, Courteney Wettemann, Nathan Holland, Brad Finegood, Thea Oliphant-Wells et al. · 2024 · Western Journal of Emergency Medicine
Medicare Payment for Opioid Treatment Programs
Carter H. Nakamoto, Haiden A. Huskamp, Julie M. Donohue, Michael L. Barnett, Adam J. Gordon, Ateev Mehrotra · 2024 · JAMA Health Forum
Buprenorphine for Opioid Use Disorder—An Essential Medical Treatment
Melissa B. Weimer, Kenneth L. Morford · 2024 · JAMA Internal Medicine
Immediate Effects of Mindful Awareness in Body-Oriented Therapy as an Adjunct to Medication for Opioid Use Disorder
Cynthia J Price, Kenneth C. Pike, Anna Treadway, Julia K. Palmer, Joseph O. Merrill · 2024 · Mindfulness
Addiction Consult Services, Mortality, and Acute Care Utilization in Inpatients With Opioid Use Disorder
Yasna Rostam Abadi, Scarlett Wang, Carla King, Roopa Kalyanaraman Marcello, Gretchen Van Wye, Ellenie D. Tuazon, Joseph Kennedy, Caroline Cooke, Medha Mazumdar, Thaddeus Tarpey et al. · 2025 · JAMA Network Open
Community pharmacy-based injectable naltrexone service delivery models and best practices
James H. Ford, Aaron M. Gilson, Gina M. Bryan, Caroline Augustine, Michele Gassman, David A. Mott · 2020 · Research in Social and Administrative Pharmacy
Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder
Alene Kennedy‐Hendricks, Cameron J. Schilling, Alisa B. Busch, Elizabeth A. Stuart, Haiden A. Huskamp, Mark Katz Meiselbach, Colleen L. Barry, Matthew D. Eisenberg · 2021 · Journal of General Internal Medicine
Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study
Keith J. Zullig, Laura R. Lander, Meghan Tuscano, Megan Garland, Gerry R. Hobbs, Laurel Faulkenberry · 2021 · Mindfulness
Variation in emergency department visit rates for opioid use disorder: Implications for quality improvement initiatives
Utsha G. Khatri, Elizabeth A. Samuels, Ruiying Aria Xiong, Brandon D. L. Marshall, Jeanmarie Perrone, Mucio Kit Delgado · 2021 · The American Journal of Emergency Medicine
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants
Barbara Andraka‐Christou, Cory Page, Victoria Schoebel, Jessica Buche, Rebecca L. Haffajee · 2022 · Addiction Science & Clinical Practice
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States
Tianyu Sun, Natallia Katenka, Stephen J Kogut, Jeffrey P. Bratberg, Josiah D. Rich, Ashley L Buchanan · 2022 · Pharmacoepidemiology
Availability of timely methadone treatment in the United States and Canada during COVID-19: A census tract-level analysis
Ofer Amram, Leah Rosenkrantz, Solmaz Amiri, Nadine Schuurman, Victoria Panwala, Paul J. Joudrey · 2023 · Drug and Alcohol Dependence
Association of Patients’ Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder
Jarratt D. Pytell, Penn Whitley, Steven D. Passik, William L. Bundy, Eric Dawson, Brendan K. Saloner · 2023 · JAMA Psychiatry
Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care
Joanna Krupp, Frances Hung, Tina LaChapelle, Michael Edwards Yarrington, Katherine Link, Yujung Choi, Hillary Chen, Andrea C. Des Marais, Nidhi Sachdeva, Hrishikesh Chakraborty et al. · 2023 · Southern Medical Journal
Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study
Anna K. Martin, Tyshaun Perryman, Judith Bernstein, Jessica L. Taylor, Ricardo Cruz, Jordana R. Muroff, Jeffrey H. Samet, Sabrina A. Assoumou · 2023 · Drug and Alcohol Dependence Reports
Advocacy for patients with opioid use disorder: A primer for physicians and other clinicians on the Americans with Disabilities Act
Anna-Maria South, Laura C. Fanucchi, Michelle R. Lofwall · 2023 · Journal of Opioid Management
Circumstances of death of opioid users being treated with naltrexone
Shane G Darke, Michael Farrell, Johan A Duflou, Briony Larance, Julia Lappin · 2019 · Addiction
The time for emergency department opioid agonist therapy is now: “A BC perspective”
Andrew M. Kestler, Jason Wale, Melissa Allan · 2019 · Canadian Journal of Emergency Medicine
Limited Access to On-Label Formulations of Buprenorphine for Chronic Pain as Compared with Conventional Opioids
Michael Alan Fishman, Ashley M. Scherer, Jacob Topfer, Philip S. Kim · 2019 · Pain Medicine
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study
Ryan P. McCormack, John Rotrosen, Phoebe R Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch, Patricia Novo, David Shalom Liu, Eva Jennifer Edelman, Sarah Farkas et al. · 2021 · Addiction Science & Clinical Practice
Treatment approaches and outcome trajectories for youth with high‐risk opioid use: A narrative review
Jean N. Westenberg, Andy Man Yeung Tai, Julie Elsner, Mostafa Mamdouh Kamel, James S.H. Wong, Pouya Azar, Dzung X. Vo, Eva M. Moore, Nickie Mathew, Vijay Seethapathy et al. · 2021 · Early Intervention in Psychiatry
A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions
Ali Pourmand, Kamilla Beisenova, Nebiyu Shukur, Collin Tebo, Nakita Mortimer, Maryann E. Mazer-Amirshahi · 2021 · The American Journal of Emergency Medicine
Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality
Caroline A. King, Honora L. Englander, Philip Todd Korthuis, Joshua A. Barocas, Kenneth John McConnell, Cynthia D. Morris, Ryan Cook · 2021 · PLoS ONE
Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy
Sugy Choi, Michael D. Stein, Julia Raifman, David Rosenbloom, Jack Allen Clark · 2021 · Drug and Alcohol Dependence
Nudging Emergency Department-Initiated Addiction Treatment
Kelley Butler, Tyler J. Chavez, Sarah E. Wakeman, Ted Robertson, Jessica H. Leifer, Jeremy T Barofsky, Lee‐Sien Kao, Jaclyn Lefkowitz, Sayon Dutta, Bryan D. Hayes et al. · 2021 · Journal of Addiction Medicine
Optimally Choosing Medication Type for Patients With Opioid Use Disorder
Kara E. Rudolph, Nicholas Williams, Ivan Matos Diaz, Sean X. Luo, John Rotrosen, Edward V. Nunes · 2022 · American Journal of Epidemiology
Enhancing Treatment Access and Effectiveness: Toward Patient-Centered Models of Care
Aaron D. Fox, Andrea U. Jakubowski, Jonathan Giftos · 2019 · Current clinical psychiatry
Barriers to Assessing and Treating Trauma in Primary Care and Opportunities for Improvement: Perspectives from Prescribers of Medications for Opioid Use Disorder
Abigail K. Winiker, Omeid Heidari, Sarah Pollock, Shereen Sodder, Karin Elizabeth Tobin · 2023 · Substance Use & Misuse
Initiations of safer supply hydromorphone increased during the COVID-19 pandemic in Ontario: An interrupted time series analysis
Samantha Young, Tara Gomes, Gillian Kolla, Daniel McCormack, Zoë Dodd, Janet Raboud, Ahmed M. Bayoumi · 2023 · PLoS ONE
Medicaid Managed Care Prior Authorization For Buprenorphine Tied To State Partisanship And Health Plan Profit Status, 2018
Christina M. Andrews, Melissa A. Westlake, Amanda J. Abraham, Colleen M. Grogan, Samantha J. Harris, Sadia Jehan · 2024 · Health Affairs
Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes
Caleb J. Banta‐Green, Mandy D. Owens, Jason R. Williams, Anthony S. Floyd, Wendy Williams‐Gilbert, Susan Kingston · 2024 · Substance Abuse and Rehabilitation
Whose opinion matters about medications for opioid use disorder? A cross-sectional survey of social norms among court staff
Barbara Andraka‐Christou, Danielle N. Atkins · 2020 · Substance Abuse
Posttraumatic stress disorder in individuals seeking treatment for opioid use disorder in Vermont
Kelly R. Peck, Nathaniel Moxley‐Kelly, Gary J. Badger, Stacey C. Sigmon · 2021 · Preventive Medicine